182 related articles for article (PubMed ID: 8490920)
1. Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence.
Greven KM; Lanciano RM; Corn B; Case D; Randall ME
Cancer; 1993 Jun; 71(11):3697-702. PubMed ID: 8490920
[TBL] [Abstract][Full Text] [Related]
2. Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma.
Stewart KD; Martinez AA; Weiner S; Podratz K; Stromberg JS; Schray M; Mitchell C; Sherman A; Chen P; Brabbins DA
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):527-35. PubMed ID: 12243832
[TBL] [Abstract][Full Text] [Related]
3. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
[TBL] [Abstract][Full Text] [Related]
4. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
Citron JR; Sutton H; Yamada SD; Mehta N; Mundt AJ
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1432-8. PubMed ID: 15275729
[TBL] [Abstract][Full Text] [Related]
5. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
6. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.
Creutzberg CL; van Putten WL; Koper PC; Lybeert ML; Jobsen JJ; Wárlám-Rodenhuis CC; De Winter KA; Lutgens LC; van den Bergh AC; van de Steen-Banasik E; Beerman H; van Lent M
Lancet; 2000 Apr; 355(9213):1404-11. PubMed ID: 10791524
[TBL] [Abstract][Full Text] [Related]
7. Analysis of prognostic factors and patterns of recurrence in patients with pathologic stage III endometrial cancer.
Patel S; Portelance L; Gilbert L; Tan L; Stanimir G; Duclos M; Souhami L
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1438-45. PubMed ID: 17418961
[TBL] [Abstract][Full Text] [Related]
8. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
Klopp AH; Jhingran A; Ramondetta L; Lu K; Gershenson DM; Eifel PJ
Gynecol Oncol; 2009 Oct; 115(1):6-11. PubMed ID: 19632709
[TBL] [Abstract][Full Text] [Related]
9. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
Kuku S; Williams M; McCormack M
Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
[TBL] [Abstract][Full Text] [Related]
11. Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation.
Martinez AA; Weiner S; Podratz K; Armin AR; Stromberg JS; Stanhope R; Sherman A; Schray M; Brabbins DA
Gynecol Oncol; 2003 Sep; 90(3):537-46. PubMed ID: 13678721
[TBL] [Abstract][Full Text] [Related]
12. Survival of women with clear cell and papillary serous endometrial cancer after adjuvant radiotherapy.
Foerster R; Kluck R; Rief H; Rieken S; Debus J; Lindel K
Radiat Oncol; 2014 Jun; 9():141. PubMed ID: 24941899
[TBL] [Abstract][Full Text] [Related]
13. Is Surgical Staging Necessary for Patients with Low-risk Endometrial Cancer? A Retrospective Clinical Analysis.
Kokcu A; Kurtoglu E; Celik H; Kefeli M; Tosun M; Onal M
Asian Pac J Cancer Prev; 2015; 16(13):5331-5. PubMed ID: 26225674
[TBL] [Abstract][Full Text] [Related]
14. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
[TBL] [Abstract][Full Text] [Related]
15. Analysis of patients with stage IIIC endometrial cancer.
Turan T; Ureyen I; Duzguner I; Ozkaya E; Tasci T; Karalok A; Boran N; Kose MF; Tulunay G
Int J Gynecol Cancer; 2014 Jul; 24(6):1033-41. PubMed ID: 24905617
[TBL] [Abstract][Full Text] [Related]
16. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
17. Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.
Steiner E; Eicher O; Sagemüller J; Schmidt M; Pilch H; Tanner B; Hengstler JG; Hofmann M; Knapstein PG
Int J Gynecol Cancer; 2003; 13(2):197-203. PubMed ID: 12657124
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control?
Paydar I; DeWees T; Powell M; Mutch DG; Grigsby PW; Schwarz JK
Brachytherapy; 2015; 14(4):427-32. PubMed ID: 25911995
[TBL] [Abstract][Full Text] [Related]
19. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
20. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
